Every Friday, we’re recapping the past week in the coronavirus pandemic from our tracking, policy analysis, polling, and journalism. This past week (May 21 to 28), total deaths due to COVID-19 in the U.S. surpassed 100,000 on Wednesday, May 27. That day ended with approximately 100,400 total confirmed deaths.
- view as grid
- view as list
This week saw protests across the country voicing outrage over how widespread racism in the United States impacts black lives. Structural and systemic racism have created longstanding disparities across economic and health indicators for Black Americans – including the disproportionate impact of COVID-19 in Black communities and other communities of color.
This fact sheet identifies key U.S. government global health positions and officials.
With over 6 million pregnancies per year in the U.S., pregnant and breastfeeding women constitute a significant portion of the population that could be impacted by COVID-19. This brief summarizes what is known thus far about pregnancy and COVID-19.
This fact sheet provides a snapshot of global polio eradication efforts and examines the U.S. government’s role in addressing polio worldwide.
These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries.
The U.S. Response to Coronavirus: Summary of the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, which was passed with near unanimous support in both the House and Senate, was signed into law by the President on March 6, 2020. The bill provides $8.3 billion in emergency funding for federal agencies to respond to the coronavirus outbreak. This summary provides details on funding specified in the bill.
This fact sheet explains the U.S. government’s role in addressing the global tuberculosis (TB) epidemic, including the history of U.S. involvement and funding trends.
New federal legislation will require most private health plans to cover testing for the coronavirus with no cost sharing. Some states have adopted similar requirements for insurers they regulate, and many private insurance companies will voluntarily expand coverage for testing. However, some private coverage will not be subject to these requirements. To date, fewer changes have been adopted or considered with respect to treatment for complications from the disease. This brief reviews current coverage standards for private health plans and how these may change in response to the COVID-19 pandemic.
As we navigate how to communicate about COVID-19 and the urgent public health issues it brings, there is much that can be learned in looking at HIV messaging and how it has evolved. This blog discusses some of our observations from KFF’s more than two decades of experience running large-scale public information campaigns about HIV and other communicable diseases that have bearing in this new environment.